Today Vertex Pharmaceuticals Inc. announced the two next-generation CFTR modulator candidates that will progress into Phase 3 clinical trials.
Site Search
Showing 11 - 20 of 171 results
News
|
Jan. 31, 2018
|
4 min read
Yesterday, President Donald J. Trump signed the Right to Try bill into law. The House approved the bill last week and the Senate passed it last summer.
News
|
May 31, 2018
|
3 min read
Press Release
|
Oct. 3, 2005
|
5 min read
Press Release
|
Jan. 18, 2006
|
3 min read
The Patient Registry is an invaluable tool for researchers conducting observational studies about people with CF in the U.S. About 50,000 individuals have been followed in the Registry since its inception in 1986; many of them have been included for over 20 years.
4 min read
The Success with Therapies Research Consortium helps the clinical study of interventions so people with cystic fibrosis can improve the consistency of their day-to-day management of their CF to optimize health outcomes and quality of life.
7 min read
Revised Law Includes Designated Funding for Rare Diseases
Press Release
|
April 24, 2008
|
2 min read
News
|
Sept. 26, 2008
|
1 min read
News
|
June 29, 2009
|
1 min read
News
|
July 16, 2009
|
2 min read